Of note, MBNL2 regulates cancer migration and invasion through PI3K/AKT-mediated EMT (Lin et al., 2021) and its overexpression in breast and cancer cell lines inhibits their metastatic potential (Zhang et al., 2019b). The gene discussed is AKT1; the disease is cancer.